Combine that with a CDA, and it's pretty easy to see that the company cannot release any information about the P2b interim analysis until they release it, to the chagrin of most of the turds in the punch bowl "over there". Thanks again for swatting those pesky flies, Sox.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Lord, help me to be the person that my dogs think I am...